RSS Feed – News

  • Dean Investment Associates Lifted By $508860 Its Price T Rowe Group (TROW) Holding; 10 …
    The companyÂ's principle programs include AMT-060, a gene therapy that has completed Phase I/II clinical trial for the treatment of hemophilia B; S100A1, a preclinical product candidate for the treatment of congestive heart failure; and AMT-130 for the treatment of huntington's disease. It currently has  ... read more
    Source: Google NewsPublished on 2018-01-18
  • Head-To-Head Analysis: GTX (GTXI) & Wave Life Sciences (NASDAQ:WVE)
    The Company is engaged in developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins ... The Company has three programs in Huntington's disease (HD) and Duchenne Muscular Dystrophy (DMD), and three additional development candidates. ... read more
    Source: Google NewsPublished on 2018-01-18
  • uniQure Advancing AMT-130 Development in the New Year
    In 2018, uniQure N.V. expects to advance the clinical development of AMT-130, its investigational gene therapy for the treatment of Huntington's disease (HD). ... HD is a genetic, neurodegenerative disorder that leads to loss of muscle coordination, behavioral abnormalities and cognitive decline. ... read more
    Source: Google NewsPublished on 2018-01-18
  • uniQure Aims to Begin First Human Trial of Investigational Gene Therapy AMT-130 for Huntington’s
    uniQure expects to advance the clinical development of its Huntington's disease investigational gene therapy, called AMT-130, during 2018. The company says it plans to file an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) in the second half of 2018. ... read more
    Source: Google NewsPublished on 2018-01-18
  • H. Lundbeck A/S- Expected to Post FY2017 Earnings of $2.44 Per Share (HLUYY)
    H. Lundbeck A/S- (OTCMKTS:HLUYY) – Research analysts at Jefferies Group boosted their FY2017 EPS estimates for shares of H. Lundbeck A/S- in a research report issued on Tuesday. Jefferies Group analyst P. Welford now expects that the company will earn $2.44 per share for the year, up from  ... read more
    Source: Google NewsPublished on 2018-01-18
  • Suven Life Sciences secures 2 overseas product patents
    ... agents for major depressive disorders and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Narcolepsy, Parkinson and Schizophrenia respectively. ... read more
    Source: Google NewsPublished on 2018-01-18
  • Suven Life Sciences rises 3% on product patents in China, Sri Lanka
    ... are being developed as therapeutic agents for major depressive disorders and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Narcolepsy, Parkinson and  ... read more
    Source: Google NewsPublished on 2018-01-18
  • Market Live: Banks lift Sensex over 350 pts; RBL, Federal, DCB & other regional lenders may rally
    ... major depressive disorders and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer's disease, Attention deficient hyperactivity disorder (ADHD), Huntington's disease, Narcolepsy, Parkinson and Schizophrenia respectively, the company said. ... read more
    Source: Google NewsPublished on 2018-01-17
  • Director, Co-Founder Resort Area Ministries Has Died
    High Country Press reports the co founder and long time director of Resort Area Ministries, died January 13th. Moore was a native of Haywood County and a graduate of the Southern Baptist Theological Seminar. According to the report, Moore was diagnosed with Huntington's Disease 17 years ago. ... read more
    Source: Google NewsPublished on 2018-01-17
  • TDP-43 Snarls Nuclear Traffic
    Indeed, disruptions of nucleocytoplasmic transport repeatedly surfaced last year in studies of ALS/FTD, as well as Huntington's and Alzheimer's disease (Kim and Taylor, 2017; Dec 2017 conference news). Clues that nucleocytoplasmic transport might be disrupted in ALS date back to 1995 (Vuopala et  ... read more
    Source: Google NewsPublished on 2018-01-17
  • The chronically-ill patients who need cannabis to ease their pain
    The family faced further heartbreak when Dawn's ex-husband Iain was diagnosed with Huntington's disease – a brain disorder that effects behaviour and judgement. “He also has an ailment which would be improved by cannabis as it would reduce his tremors,” she added. “My children face being  ... read more
    Source: Google NewsPublished on 2018-01-17
  • Carer left Huntington’s Disease sufferer ‘outside to get sunburned’ and ‘in urine-soaked bed’
    A trial at Manchester Crown heard that Mrs Parkin suffers from Huntington's Disease, a degenerative brain condition which means she is not able to walk, cannot communicate verbally and suffers from involuntary movements. Outlining the case against the Mufakasi, Henry Blackshaw told the jury: “The  ... read more
    Source: Google NewsPublished on 2018-01-17
  • Why Gene Silencing Could Launch a New Class of Blockbuster Drugs
    For a while, it seemed as if gene silencing was slowly being relegated to the annals of forgotten scientific history. Until now. Last month, Ionis Pharmaceutical announced positive results for a groundbreaking gene silencing trial for Huntington's disease. The drug, an anti-sense oligonucleotide (ASO),  ... read more
    Source: Google NewsPublished on 2018-01-17
  • High Country Mourns Death of Tom Moore, Former Director of Resort Area Ministries
    The High Country is mourning the death of Thomas “Tom” David Moore, who at 66 died January 13 following a long-time and very brave battle with Huntington's Disease. Best known for his 34 years as director of Resort Area Ministries, of which he was co-founder, Moore will be remembered for ... read more
    Source: Google NewsPublished on 2018-01-17
  • Brokerages Expect H. Lundbeck A/S- (HLUYY) to Post $0.31 EPS
    Shares of H. Lundbeck A/S- (NASDAQ:HLUYY) have received an average broker rating score of 1.00 (Strong Buy) from the one analysts that provide coverage for the company, Zacks Investment Research reports. One equities research analyst has rated the stock with a strong buy rating. Zacks has also  ... read more
    Source: Google NewsPublished on 2018-01-17
  • Huntington’s disease: The facts
    Huntington's disease is an illness caused by a faulty gene in your DNA (the biological 'instructions' you inherit which tell your cells what to do). If you have Huntington's, it affects your body's nervous system – the network of nerve tissues in the brain and spinal cord that co-ordinate your ... read more
    Source: Google NewsPublished on 2018-01-17
  • New discovery could radically change what we know about Alzheimer’s
    Is it possible that our therapeutic treatment options for Alzheimer's disease have been going about it the wrong way? ... But, if it is proven to be an effective treatment, someone with the affected gene, or who has yet to develop symptoms of Huntington's, would receive the spinal injections approximately  ... read more
    Source: Google NewsPublished on 2018-01-17
  • Global Neuroprotective Products Market Key Players & Growth Rate 2018: Ceregene, NeuroVive …
    Based on treatment of medical condition, the global Neuroprotective Products market is segmented into Alzheimer's disease, Multiple sclerosis, Parkinson's disease, Ocular degeneration (retinal disorders), Amyotrophic lateral sclerosis (ALS), Huntington's disease, Neuropathies. All segments are  ... read more
    Source: Google NewsPublished on 2018-01-17
  • Carer pulled Huntington’s Disease sufferer ‘like rag doll’ and put her outside to get sunburned …
    A carer pulled a Huntington's Disease sufferer 'like a rag doll', left her in a urine-soaked bed and put her outside to get sunburned, a court has heard. Beauty Mufakasi, from Moston, denies two counts of ill treatment or wilful neglect of Lorraine Parkin, 46, for whom she was a ... read more
    Source: Google NewsPublished on 2018-01-17
  • 7 terrifying diseases you could have without knowing it
    Huntington's disease is a genetic disorder that causes the degeneration of nerve cells in the brain. This disease can be present without any symptoms, but by the time symptoms appear, it develops quite rapidly. In some cases, symptoms can start before the age of twenty in the form of learning ... read more
    Source: Google NewsPublished on 2018-01-16
  • Huntington’s therapy hints commitment in a small trial
    Huntington's therapy proved to be a blessing in disguise for those patients who are struggling with Huntington's disease, a brain affliction that incapacitates the body and blurs speech and thinking after the age of 30. Huntington's like other neurodegenerative diseases such as Lou Gehrig's, Parkinson's  ... read more
    Source: Google NewsPublished on 2018-01-16
  • Donald Trump scores top marks in Montreal cognitive test – how well would you do?
    The MoCA has been found to be useful to detect mild cognitive impairment in many conditions including Alzheimer's disease, Vascular Cognitive Impairment, Parkinson's disease, multiple sclerosis, Huntington's disease and head trauma. Test instructions may be repeated once, however items listed in  ... read more
    Source: Google NewsPublished on 2018-01-16
  • Chair City residents donate to Huntington’s research
    Members of First Presbyterian Church filed into the office at Wake Forest Baptist Health's facility at Piedmont Plaza to present a check to go toward Walker's Huntington's disease research. The donation was contributed in memory of Gail Moore, a member of First Presbyterian who passed away from  ... read more
    Source: Google NewsPublished on 2018-01-16
  • NeuroBreak: Alzheimer’s Germ Contest; High Salt Diet May Be Bad for Brain
    ... $1 billion in sales in its first nine months on the market. (Endpoints News). Scientific American takes a deeper dive into antisense therapies targeting mutant HTT as a treatment for Huntington's disease. Find out how neurologists are addressing the need for diversity in their specialty. (Neurology Today). ... read more
    Source: Google NewsPublished on 2018-01-16
  • Chorea Market Value Share 11.4% | Industry Key Factor Analysis | Top 10 Key Players …
    ... 2017, Teva Pharmaceutical Industries Ltd. received FDA approval for AUSTEDO™ (deutetrabenazine) for the treatment of chorea associated with Huntington's disease (HD). Huntington's disease (HD) affects more than 35,000 people in the United States. Various other companies such as Pfizer is also  ... read more
    Source: Google NewsPublished on 2018-01-16
  • Strict Meal Schedule May Benefit Huntington’s Patients, UCLA Mouse Study Suggests
    A research team at University of California-Los Angeles (UCLA) decided to evaluate if controlling meal schedules could help improve circadian rhythmicity in Huntington's patients, thereby delaying progression of the disease. To do that, they used a mouse model of Huntington's that replicates many  ... read more
    Source: Google NewsPublished on 2018-01-16
  • Experimental Huntington’s Therapy Shows Promise in a Small Trial
    Many stormed in, Tabrizi suspects, after hearing news last month about a potential new therapy for Huntington's disease, a brain disorder that cripples the body and blurs speech and thinking, sometimes not too long after a person's 30th birthday. Like other neurodegenerative disorders such as Lou  ... read more
    Source: Google NewsPublished on 2018-01-16
  • Global Invasive Brain Monitoring Device Market 2018- Advanced Brain Monitoring , Siemens …
    In the opening part, Invasive Brain Monitoring Device Market study trades with the complete survey of the Invasive Brain Monitoring Device market, which consists of definitions, a wide range of applications (Epilepsy, Dementia, Parkinson?s Disease, Huntington's Disease, Headache Disorders, Stroke,  ... read more
    Source: Google NewsPublished on 2018-01-16
  • Daughter fears disabled mother will lose her lifeline carers
    Lizzie was also diagnosed with Huntington's Disease, just months after it robbed her mum of her ability to walk and talk. The devoted daughter, 29, knew it would happen – she had watched as the illness slowly ground her mother down. Lizzie had been forced to pick up the slack ... read more
    Source: Google NewsPublished on 2018-01-16
  • Huntington’s Disease Therapeutics Market 2021 to Register High Growth of 14.75%: Top …
    Huntington's Disease Therapeutics Market report covers information on market status & trend of the report by 2017-2021 with top manufacturers which offers a complete assessment of the latest trends of the Huntington's Disease Therapeutics Industry. Huntington's Disease Therapeutics Market report  ... read more
    Source: Google NewsPublished on 2018-01-15
  • What’s happening Tuesday in the north valley
    Huntington's Disease Support Group: 6:30 p.m. Help, sharing and education. Enloe Regional Cancer Center library, 265 Cohasset Road. Lori, 896-9257 or email lorirollin@gmail.com and write HDSA in subject line. Third Tuesday. Chico Community Band: 7-9 p.m. CARD activity. Musicians who play  ... read more
    Source: Google NewsPublished on 2018-01-15
  • Medical marijuana dispensary in Malvern area prepares to open
    Medical marijuana in Pennsylvania has been approved for 17 conditions: ALS, autism, cancer, Chrohn's Disease, epilepsy, glaucoma, HIV/AIDS, Huntington's Disease, inflammatory bowel disease, intractable spasticity, Multiple Sclerosis, neuropathies, Parkinson's Disease, Post-Traumatic Stress  ... read more
    Source: Google NewsPublished on 2018-01-15
  • Huntington’s Disease Therapeutics Market 2021 Type Segment, Industry Segment, Market …
    Huntington's Disease Therapeutics Market report provide emerging opportunities in the market and the future impact of major drivers and challenges and, support decision makers in making cost-effective business decisions. The Huntington's Disease Therapeutics Market is anticipated to increase at a  ... read more
    Source: Google NewsPublished on 2018-01-15
  • The Spanish ‘biotech’, fashionable among investors
    Ten million euros captured SOM Biotech to accelerate its expansion in the American market, where it has opened its first international office, and fund two trials related to Huntington's disease and adrenoleukodystrophy programs. Universal DX, which is developing a test to diagnose colon cancer,  ... read more
    Source: Google NewsPublished on 2018-01-15
  • Virginia Medicaid Nursing Home Residents With Dementia & A Psychiatric Diagnosis Rose 40%
    In 2011, about 1.5% of Virginia Medicaid long-stay residents with dementia and taking an antipsychotic also had a diagnosis of schizophrenia, Tourette's syndrome, or Huntington's disease. In 2013, about 2.1% of such residents had one of the three psychiatric diagnoses. During the five years prior to  ... read more
    Source: Google NewsPublished on 2018-01-14
  • Science and Innovation: Stem cell therapies not ready for market
    Barker's own research includes the use of stem cells in developing cures for Parkinson's and Huntington's disease. “There are a lot of clinics offering unproven stem cell therapies for all sorts of conditions, and the problem is that the science underpinning these is either very poor or non-existent,” he says. ... read more
    Source: Google NewsPublished on 2018-01-14
  • Living with dementia: Families share their stories to help others
    Joy Cheeseman's 83-year-old mother Mary was diagnosed with Alzheimer's disease just over 10 years ago. Joy's main piece of advice to people who suspect their relatives have dementia, to see the doctor as soon as possible. Joy said: “If they have any inklings that there is a possibility that their ... read more
    Source: Google NewsPublished on 2018-01-14
  • Williams, Eugenia Jennings
    Later in life, after the joy of dancing was taken from her by Huntington's Disease, Genii and Tim enjoyed traveling to study nature and to learn the culture and crafts of the many and varied tribes of Native Americans. Genii and Tim were one, and she will be sorely missed. ... read more
    Source: Google NewsPublished on 2018-01-13
  • Analysis of Triplet Repeat Disorders. Human Molecular Genetics – Biology and Life Sciences …
    The clinical picture of diseases, caused by trinucleotide repeats, such as fragile X syndrome, myotonic dystrophy, Huntington's disease and forms of ... The book proceeds to integrate the current understanding of the molecular pathologies of these diseases, their genotype-phenotype relationships, the  ... read more
    Source: Google NewsPublished on 2018-01-13
  • Do you know about Huntington’s disease? A genetic disorder
    Huntington's disease is a genetic disorder which can be fatal in nature. It is caused by a defect in a single gene which causes mutant proteins. It also causes progressive breakdown of nerve cells in the brain and deteriorates a person's physical and mental abilities. ... read more
    Source: Google NewsPublished on 2018-01-13
  • PROPSTER, Mark
    ... morning at 9:30 followed by a Mass of Christian Burial at St. Andrew's Church (corner of Reiman and Crocker Sts.), Sloan, N,Y at 10 AM. In lieu of flowers, donations may be made to the Huntington's Disease Society of America (HDSA), 505 Eighth Ave., Suite 902, New York, NY ... read more
    Source: Google NewsPublished on 2018-01-12
  • Brain Disease Market Research Report – Forecast 2017 – 2025
    The major concerned brain disease are caused due to brain deterioration which may lead to neurodegenerative diseases such as Alzheimer's, Huntington's disease, and others. The mental disorders or mental illness occurrence is also related to the brain diseases, which include depression, anxiety,  ... read more
    Source: Google NewsPublished on 2018-01-12
  • New potential drug target for Huntington’s disease identified: study
    CHICAGO, Jan. 12 (Xinhua) -- A team of researchers from several universities and research institutions has identified a new drug target for treating Huntington's disease, an inherited fatal neurological disorder. The researchers started with a drug screen using a cell model of Huntington's disease. ... read more
    Source: Google NewsPublished on 2018-01-12
  • Researcher discovers commonalities in brains of people with HD and PD
    (Boston)--A new study strongly suggests that the brains of people who have died of Huntington's disease (HD) and Parkinson's disease (PD) show a similar response to a lifetime of neurodegeneration, despite being two very distinct diseases. The findings, which appear in the journal Frontiers in  ... read more
    Source: Google NewsPublished on 2018-01-12
  • Study finds overall pattern of commonality between Huntington’s and Parkinson’s
    A new study strongly suggests that the brains of people who have died of Huntington's disease (HD) and Parkinson's disease (PD) show a similar response to a lifetime of neurodegeneration, despite being two very distinct diseases. The findings, which appear in the journal Frontiers in Molecular  ... read more
    Source: Google NewsPublished on 2018-01-12
  • This enzyme could be a drug target for Huntington’s
    Researchers have identified a new drug target for treating Huntington's disease, a fatal neurological disorder for which there currently is no cure or preventative therapy. Huntington's is an inherited disorder caused by a defect in a single gene, which causes mutant proteins to aggregate in cells. ... read more
    Source: Google NewsPublished on 2018-01-12
  • Researchers identify new potential drug target for Huntington’s disease
    Huntington's is an inherited disorder caused by a defect in a single gene, which causes mutant proteins to aggregate in cells. The disease triggers the progressive breakdown of nerve cells in the brain, producing severe physical and neurological damage that continues to get worse over time. ... read more
    Source: Google NewsPublished on 2018-01-12
  • Voyager Therapeutics Inc (VYGR) Stake Boosted by Adage Capital Partners GP LLC
    ... diseases of the central nervous system (CNS). The Company's product pipeline includes programs for Parkinson's disease, a monogenic form of amyotrophic lateral sclerosis (ALS), Friedreich's ataxia, Huntington's disease, spinal muscular atrophy (SMA), frontotemporal dementia, Alzheimer's disease  ... read more
    Source: Google NewsPublished on 2018-01-11
  • Ann Beetz, speech pathologist who taught at Loyola University, dies
    Ann Beetz, a speech pathologist who taught at Loyola University, died Jan. 6 of Huntington's disease. (Handout). Jacques KellyContact ReporterThe Baltimore Sun. Ann Lambdin Beetz, a retried speech pathologist, died Jan. 6 of Huntington's disease at Stella Maris Hospice in Timonium. She was 68  ... read more
    Source: Google NewsPublished on 2018-01-11
  • Pa.’s first legal marijuana harvest this month, in shops by Valentines Day
    The medical conditions covered by the Pennsylvania law: Amyotrophic Lateral Sclerosis; autism; cancer; Crohn's Disease; damage to the nervous tissue of the spinal cord with intractable spasticity; epilepsy; glaucoma; HIV/AIDS; Huntington's Disease; Inflammatory Bowel Disease; intractable seizures;  ... read more
    Source: Google NewsPublished on 2018-01-11